186 related articles for article (PubMed ID: 38383935)
1. Acetylcholine Analog-Modified Albumin Nanoparticles for the Enhanced and Synchronous Brain Delivery of Saponin Components of Panax Notoginseng.
Yu Y; Wang LY; Liu YC; Cui H; Yuan C; Wang CX
Pharm Res; 2024 Mar; 41(3):513-529. PubMed ID: 38383935
[TBL] [Abstract][Full Text] [Related]
2. Borneol enhances the protective effect against cerebral ischemia/reperfusion injury by promoting the access of astragaloside IV and the components of Panax notoginseng saponins into the brain.
Zhu QY; Tang S; Yang XQ; Ding H; Liu XD; Zeng XB; Huang XP; Deng CQ
Phytomedicine; 2022 Jan; 94():153822. PubMed ID: 34763313
[TBL] [Abstract][Full Text] [Related]
3. Panax notoginseng saponins provide neuroprotection by regulating NgR1/RhoA/ROCK2 pathway expression, in vitro and in vivo.
Shi X; Yu W; Yang T; Liu W; Zhao Y; Sun Y; Chai L; Gao Y; Dong B; Zhu L
J Ethnopharmacol; 2016 Aug; 190():301-12. PubMed ID: 27288754
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting adhesion events by Panax notoginseng saponins and Ginsenoside Rb1 protecting arteries via activation of Nrf2 and suppression of p38 - VCAM-1 signal pathway.
Fan J; Liu D; He C; Li X; He F
J Ethnopharmacol; 2016 Nov; 192():423-430. PubMed ID: 27620662
[TBL] [Abstract][Full Text] [Related]
5. Preparation and In Vitro and In Vivo Evaluation Of Panax Notoginseng Saponins-loaded Nanoparticles Coated with Trimethyl Chitosan Derivatives.
Chen H; Zhao Y; Li R; Chen B; Luo Z; Shi Y; Wang K; Zhang W; Lin S
J Pharm Sci; 2022 Jun; 111(6):1659-1666. PubMed ID: 34752811
[TBL] [Abstract][Full Text] [Related]
6. [In vivo distribution and pharmacokinetics of multiple effective components contained in Panax notoginseng saponins after intratympanic administration].
Chen G; Mu L; Zhang X; Hou S; Nan H
Zhongguo Zhong Yao Za Zhi; 2011 Jul; 36(13):1815-20. PubMed ID: 22032151
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and Oral Bioavailability of
Fu X; Chen K; Li Z; Fan H; Xu B; Liu M; Guo L; Xie Z; Liu K; Zhang S; Kou L
J Agric Food Chem; 2023 Jan; 71(1):469-479. PubMed ID: 36576094
[No Abstract] [Full Text] [Related]
8. Promoting oral absorption of Panax notoginseng saponins via thiolated trimethyl chitosan and wheat germ agglutinin-modified nanoformulation.
Fang R; Zhao Y; Lin S; Wei Y; Chen H
Drug Deliv Transl Res; 2024 Mar; 14(3):621-636. PubMed ID: 37787882
[TBL] [Abstract][Full Text] [Related]
9. [Major hypoglycemic ingredients of Panax notoginseng saponins for treating diabetes].
Zhong ZD; Wang CM; Wang W; Shen L; Chen ZH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Mar; 45(2):235-9. PubMed ID: 24749347
[TBL] [Abstract][Full Text] [Related]
10. Preparation and evaluation of lecithin/zein hybrid nanoparticles for the oral delivery of Panax notoginseng saponins.
Fu W; Liang Y; Xie Z; Wu H; Zhang Z; Lv H
Eur J Pharm Sci; 2021 Sep; 164():105882. PubMed ID: 34000426
[TBL] [Abstract][Full Text] [Related]
11. Endothelium-dependent vasodilation effects of
Wang Y; Ren Y; Xing L; Dai X; Liu S; Yu B; Wang Y
Exp Ther Med; 2016 Dec; 12(6):3998-4006. PubMed ID: 28101178
[No Abstract] [Full Text] [Related]
12. Brain distribution pharmacokinetics and integrated pharmacokinetics of Panax Notoginsenoside R1, Ginsenosides Rg1, Rb1, Re and Rd in rats after intranasal administration of Panax Notoginseng Saponins assessed by UPLC/MS/MS.
Guo Q; Li P; Wang Z; Cheng Y; Wu H; Yang B; Du S; Lu Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct; 969():264-71. PubMed ID: 25203723
[TBL] [Abstract][Full Text] [Related]
13. Q-marker based strategy for CMC research of Chinese medicine: A case study of Panax Notoginseng saponins.
Zhong Y; Zhu J; Yang Z; Shao Q; Fan X; Cheng Y
Phytomedicine; 2018 May; 44():129-137. PubMed ID: 29452723
[TBL] [Abstract][Full Text] [Related]
14. Lyophilization enhances the stability of Panax notoginseng total saponins-loaded transfersomes without adverse effects on ex vivo/in vivo skin permeation.
Lu Y; Cheng B; Shan Y; Zhou S; Xu C; Fei Y; Pan J; Piao J; Li F; Zhu Z; Zheng H
Int J Pharm; 2024 Jan; 649():123668. PubMed ID: 38048891
[TBL] [Abstract][Full Text] [Related]
15. New dammarane-type triterpenoid saponins from
Li Q; Yuan M; Li X; Li J; Xu M; Wei D; Wu D; Wan J; Mei S; Cui T; Wang J; Zhu Z
J Ginseng Res; 2020 Sep; 44(5):673-679. PubMed ID: 32913396
[TBL] [Abstract][Full Text] [Related]
16. Panax notoginseng saponins inhibits oxidative stress- induced human nucleus pulposus cell apoptosis and delays disc degeneration in vivo and in vitro.
Guo D; Yu M; Guo H; Zeng M; Shao Y; Deng W; Qin Q; Li Y; Zhang S
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117166. PubMed ID: 37716491
[TBL] [Abstract][Full Text] [Related]
17. [Preparation of modified rosin bonded silica high performance liquid chromatographic stationary phase and separation of Panax notoginseng saponins].
Xie W; Xia L; Li H; Li W; Cao Y; Huang Y; Lei F
Se Pu; 2022 Mar; 40(3):234-241. PubMed ID: 35243833
[TBL] [Abstract][Full Text] [Related]
18.
Hu S; Wu Y; Zhao B; Hu H; Zhu B; Sun Z; Li P; Du S
Molecules; 2018 Oct; 23(11):. PubMed ID: 30373188
[TBL] [Abstract][Full Text] [Related]
19. Anti-diabetic effects of Panax notoginseng saponins and its major anti-hyperglycemic components.
Yang CY; Wang J; Zhao Y; Shen L; Jiang X; Xie ZG; Liang N; Zhang L; Chen ZH
J Ethnopharmacol; 2010 Jul; 130(2):231-6. PubMed ID: 20435129
[TBL] [Abstract][Full Text] [Related]
20. Global gene expression analysis using RNA-seq reveals the new roles of Panax notoginseng Saponins in ischemic cardiomyocytes.
Chen S; Wu Y; Qin X; Wen P; Liu J; Yang M
J Ethnopharmacol; 2021 Mar; 268():113639. PubMed ID: 33301914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
